OCCURRENCE AND SIGNIFICANCE OF DIASTEREOMERS OF METHOTREXATE ALPHA-PEPTIDES

被引:11
作者
KUEFNER, U [1 ]
ESSWEIN, A [1 ]
LOHRMANN, U [1 ]
MONTEJANO, Y [1 ]
VITOLS, KS [1 ]
HUENNEKENS, FM [1 ]
机构
[1] SCRIPPS CLIN & RES FDN, RES INST, DEPT MOLEC & EXPTL MED, DIV BIOCHEM, LA JOLLA, CA 92037 USA
关键词
D O I
10.1021/bi00498a017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The L,L diastereomer of methotrexate-α-alanine (L,L-MTX-Ala) was synthesized by reaction of α-L-glutamyl-L-alanine di-tert-butyl ester with 4-amino-4-deoxy-10-methylpteroic acid, followed by removal of the blocking groups. It was identified by HPLC (C18 reversed-phase silica gel; acetic acid/CH3OH) as the slower of two closely spaced components in DL,L-MTX-Ala prepared previously by a different route [Kuefner et al. (1989) Biochemistry 28, 2288-2297], The L,L diastereomer was hydrolyzed by pancreatic carboxypeptidase A (to yield MTX and Ala) twice as rapidly as the DL,L mixture. Analysis of the latter by HPLC established that the slower component was hydrolyzed to MTX and that the unreactive, faster component was D,L-MTX-Ala. DL,L-MTX-Arg was resolved by HPLC (NH4OAc/CH3CN) into two closely spaced components, and the diastereomers were partially separated by chromatography on DEAE-Trisacryl (H2O → 2% NH4HCO3). Serum carboxypeptidase N hydrolyzed only the slower HPLC component (to yield MTX and Arg), thereby identifying it as the L,L diastereomer. When tested for cytotoxicity against L1210 cells, L,L-MTX-Arg (ID50 = 1.6 × 10−8 M) was more effective than the D,L diastereomer (ID50 = 2.2 × 10−7 M). Treatment of MTX with dicyclohexylcarbodiimide and N-hydroxysuccinimide (NHS), followed by hydrolysis of the NHS ester, led to racemization in the L-glutamate moiety of MTX as shown by the fact that the product was hydrolyzed by carboxypeptidase G2 (at the pteroate–Glu bond) only to the extent of ca. 50% compared to the untreated control. These observations have a broad significance, since coupling agents are employed extensively in the derivatization of MTX for attachment to affinity supports and monoclonal antibodies. © 1990, American Chemical Society. All rights reserved.
引用
收藏
页码:10540 / 10545
页数:6
相关论文
共 14 条
[1]  
Cramer S.M., Schornagel J.H., Kalghatgi K.K., Bertino J.R., Horvath C., Cancer Res., 44, pp. 1843-1846, (1984)
[2]  
Huennekens F.M., Kuefner U., Esswein A., Fan J., Montejano Y., Vitols K.S., Chemistry and Biology of Pteridines, pp. 1100-1109, (1990)
[3]  
Kuefner U., Lohrmann U., Montejano Y., Vitols K.S., Huennekens F.M., Adv. Enzyme Regul., 27, pp. 3-13, (1988)
[4]  
Kuefner U., Lohrmann U., Montejano Y.D., Vitols K.S., Huennekens F.M., Biochemistry, 28, pp. 2288-2297, (1989)
[5]  
Levy C.C., Goldman P., J. Biol. Chem., 242, pp. 2933-2938, (1967)
[6]  
McCullough J.T., Chabner B.A., Bertino J.R., J. Biol. Chem., 246, pp. 7207-7213, (1971)
[7]  
Piper J.R., Montgomery J.A., Sirotnak F.M., Chello P.L., J. Med. Chem., 25, pp. 182-187, (1982)
[8]  
Rosowsky A., Yu C.-S., J. Med. Chem., 21, pp. 170-175, (1978)
[9]  
Rosowsky A., Forsch R., Uren J., Wick M., J. Med. Chem., 24, pp. 1450-1455, (1981)
[10]  
Schweisfurth H., Reinhard E., Heinrich J., Brugger E., J. Clin. Chem. Clin. Biochem., 21, pp. 605-609, (1983)